BRIEF-Biomerieux agrees with Illumina to launch NGS epidemiology solution for service labs

* Signs exclusive agreement with Illumina to launch a next-generation sequencing (NGS) epidemiology solution for service labs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.